Genmab A/S (GMAB)
Upgrades & Downgrades
Latest GMAB news
7 Must-Buy Stocks That Are on Ridiculous Discount Now
13 November 2023
Given that this may be the year of artificial intelligence, it's no surprise that while certain enterprises have hogged the spotlight, astute investors also enjoy compelling opportunities regarding st...
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
9 November 2023
Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader pressures, generally manages to ...
Genmab to Present at Jefferies London Healthcare Conference
9 November 2023
Media Release COPENHAGEN, Denmark; November 9, 2023 Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer, Jan van de Winkel, Ph.D. and Chief Financial Officer, Anthony Pagano wil...
Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results
5 September 2023
Zai Lab Ltd.'s American depositary receipts ZLAB, +2.47% jumped 14% premarket on Tuesday after Seagen Inc. SGEN, +0.89% and Genmab A/S GMAB, +0.24% announced that Tivdak, their treatment for cervical ...
Genmab, Seagen say Tivdak cervical cancer trial met overall survival endpoint
4 September 2023
Genmab A/S , and Seagen Inc on Monday said that the Phase III trial of Tivdak in recurrent or metastatic cervical cancer patients on or after front-line therapy met its primary endpoint of overall sur...
Genmab Is Down To Attractive Levels
30 August 2023
Genmab's stock is down 15% since late 2022 highs but the company and its partners continue to execute well. The approval and launch of Epkinly for the treatment of DLBCL is a significant milestone for...
Genmab to Present at Morgan Stanley 21st Annual Global Healthcare Conference
28 August 2023
Media Release COPENHAGEN, Denmark; August 28, 2023 Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan van de Winkel, Ph.D. and Chief Financial Officer Anthony Pagano will p...
3 Biotech Stocks You Better Be Buying on Each and Every Dip
27 July 2023
Biotechnology is one of the most exciting and innovative sectors in the market, offering investors the potential for high returns coupled with groundbreaking discoveries. However, due to regulatory hu...
3 Biotech Stocks That AI is Loving in July
12 July 2023
Artificial intelligence (AI) has become an invaluable tool for investors seeking opportunities in the stock market. Its ability to analyze large amounts of data and recognize patterns makes it an ally...